How Are Drug Recalls Discovered?
January 21, 2026
Multiple Paths to Discovery
Drug recalls are rarely the result of a single dramatic discovery. Most are identified through routine systems designed to catch quality problems at various stages of a drug"s lifecycle. Understanding how recalls are discovered helps explain why some happen immediately after manufacturing while others occur months or years after a drug reaches patients.
Internal Quality Testing
Drug manufacturers are required to test every batch of medication before releasing it and to conduct ongoing stability testing of retained samples. When a batch fails a quality test — potency, purity, dissolution, sterility, or any other specification — the manufacturer must investigate. If the investigation confirms a genuine failure, the batch is recalled. Many recalls originate from this internal testing, which is why the recalling firm often discovers the problem before the FDA does.
FDA Inspections
The FDA conducts regular inspections of pharmaceutical manufacturing facilities, both domestic and foreign. These inspections can uncover problems that the manufacturer"s own quality systems missed or failed to address. Inspectors review production records, test results, complaint files, and facility conditions. When inspections reveal serious problems — documented in FDA Form 483 observations and warning letters — recalls often follow.
Some of the largest recall events in recent years have originated from FDA inspection findings at overseas manufacturing facilities, where the agency discovered data integrity problems, contamination issues, or systematic cGMP violations.
Adverse Event Reports
When patients or healthcare providers experience unexpected problems with a medication, they can report them through the FDA"s MedWatch system. A pattern of adverse event reports — unexpected side effects, therapeutic failures, or unusual product appearance — can signal a quality problem. The FDA monitors these reports and may request that a manufacturer investigate if a trend emerges.
Pharmacy and Consumer Complaints
Pharmacists sometimes notice problems that trigger recalls: tablets that look different than usual, capsules with unusual odors, or packaging that appears tampered with. Consumer complaints about a medication not working as expected can also prompt investigation. These front-line observations are an important early warning system.
Laboratory Findings and Research
Independent laboratory testing — by the FDA"s own labs, academic researchers, or third-party testing organizations — occasionally identifies contaminants that were not part of routine quality testing. The discovery of NDMA and other nitrosamine impurities in common medications like ranitidine and certain blood pressure drugs came through this kind of testing, leading to widespread recalls across multiple manufacturers.
You can explore the scope and variety of drug recalls by searching RecallDepth or browsing by classification to see how the severity of discovered problems varies.